Published in Brain on September 13, 2007
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol (2009) 3.82
Modelling neural correlates of working memory: a coordinate-based meta-analysis. Neuroimage (2011) 2.06
Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience (2009) 1.14
Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain (2009) 1.11
Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study. EBioMedicine (2015) 1.08
Functional imaging in Huntington's disease. Exp Neurol (2009) 1.08
Rhesus macaque brain morphometry: a methodological comparison of voxel-wise approaches. Methods (2009) 1.02
Irritability in pre-clinical Huntington's disease. Neuropsychologia (2009) 0.99
The importance of group-wise registration in tract based spatial statistics study of neurodegeneration: a simulation study in Alzheimer's disease. PLoS One (2012) 0.96
Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease. Brain (2012) 0.95
Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease. J Cereb Blood Flow Metab (2011) 0.92
Abnormal synchrony of resting state networks in premanifest and symptomatic Huntington disease: the IMAGE-HD study. J Psychiatry Neurosci (2014) 0.92
Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease? Ann N Y Acad Sci (2008) 0.91
Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol Dis (2010) 0.91
Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease. J Neurol Neurosurg Psychiatry (2009) 0.90
Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. J Neurol (2009) 0.89
Consistent neurodegeneration and its association with clinical progression in Huntington's disease: a coordinate-based meta-analysis. Neurodegener Dis (2012) 0.89
Emotion recognition and experience in Huntington disease: a voxel-based morphometry study. J Psychiatry Neurosci (2011) 0.89
Dual task performance in normal aging: a comparison of choice reaction time tasks. PLoS One (2013) 0.87
Reduced functional brain connectivity prior to and after disease onset in Huntington's disease. Neuroimage Clin (2013) 0.87
Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease. Brain Behav (2013) 0.85
Interregional compensatory mechanisms of motor functioning in progressing preclinical neurodegeneration. Neuroimage (2013) 0.85
Disruption of response inhibition circuits in prodromal Huntington disease. Cortex (2014) 0.84
Risk-taking and pathological gambling behavior in Huntington's disease. Front Behav Neurosci (2014) 0.84
Longitudinal task-negative network analyses in preclinical Huntington's disease. Eur Arch Psychiatry Clin Neurosci (2013) 0.83
Functional connectivity of primary motor cortex is dependent on genetic burden in prodromal Huntington disease. Brain Connect (2014) 0.81
Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers. PLoS One (2009) 0.81
Reduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortex. Neurobiol Dis (2011) 0.81
Altered hypothalamic protein expression in a rat model of Huntington's disease. PLoS One (2012) 0.79
Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease. J Neurol (2014) 0.78
Neuroimaging in Huntington's disease. World J Radiol (2014) 0.78
Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease. Neuroimage Clin (2015) 0.78
Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease. J Neurol (2015) 0.78
Prodromal Huntington disease as a model for functional compensation of early neurodegeneration. PLoS One (2014) 0.77
Default-mode network changes in Huntington's disease: an integrated MRI study of functional connectivity and morphometry. PLoS One (2013) 0.77
The many facets of unawareness in huntington disease. Tremor Other Hyperkinet Mov (N Y) (2014) 0.76
Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease. Neuropsychology (2011) 0.76
Eye-head coordination in moderately affected Huntington's Disease patients: do head movements facilitate gaze shifts? Exp Brain Res (2008) 0.76
Frontal cortex BOLD signal changes in premanifest Huntington disease: a possible fMRI biomarker. Neurology (2014) 0.76
Cognitive and autonomic dysfunction in presymptomatic and early Huntington's disease. J Neurol (2014) 0.76
Intact sensory-motor network structure and function in far from onset premanifest Huntington's disease. Sci Rep (2017) 0.75
Patients with schizophrenia show aberrant patterns of basal ganglia activation: Evidence from ALE meta-analysis. Neuroimage Clin (2017) 0.75
Effects of task difficulty during dual-task circle tracing in Huntington's disease. J Neurol (2014) 0.75
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol (2010) 3.47
Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell (2002) 2.98
Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr (2003) 2.89
Neural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2008) 2.04
Epileptic seizure following 1 Hz repetitive transcranial magnetic stimulation. Clin Neurophysiol (2006) 1.66
Investigating directed influences between activated brain areas in a motor-response task using fMRI. Magn Reson Imaging (2005) 1.61
Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY. PLoS Curr (2010) 1.45
Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis. Cereb Cortex (2004) 1.32
Concerns about pregabalin: further experience with its potential of causing addictive behaviors. J Addict Med (2013) 1.28
The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease. Mol Neurodegener (2009) 1.23
Mechanisms and applications of theta-burst rTMS on the human motor cortex. Brain Topogr (2009) 1.17
Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp Neurol (2008) 1.17
Dysfunction of the social brain in schizophrenia is modulated by intention type: an fMRI study. Soc Cogn Affect Neurosci (2009) 1.10
Pregabalin abuse and dependence in Germany: results from a database query. Eur J Clin Pharmacol (2013) 1.09
Better risk assessment for individual substances. Dtsch Arztebl Int (2015) 1.09
Desomorphine goes "crocodile". J Addict Dis (2012) 1.08
Electroconvulsive therapy in pregnancy revisited. Psychosom Med (2013) 1.08
Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention-deficit/hyperactivity disorder. Hum Brain Mapp (2009) 1.06
Increased left prefrontal activation in patients with unipolar depression: an event-related, parametric, performance-controlled fMRI study. J Affect Disord (2007) 1.06
A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset. Hum Mol Genet (2012) 1.06
Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions. Ann Neurol (2002) 1.04
Utilisation of Healthcare and Associated Services in Huntington's disease: a data mining study. PLoS Curr (2011) 1.02
Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data. J Psychiatr Res (2003) 1.02
Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease. Mov Disord (2002) 1.00
Working memory dysfunction in schizophrenia compared to healthy controls and patients with depression: evidence from event-related fMRI. Neuroimage (2007) 0.99
Aberrant connectivity of resting-state networks in borderline personality disorder. J Psychiatry Neurosci (2011) 0.99
Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations. J Psychiatry Neurosci (2011) 0.98
Temporally anticorrelated brain networks during working memory performance reveal aberrant prefrontal and hippocampal connectivity in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.98
High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo. Hum Gene Ther (2007) 0.97
Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI study. Neuroreport (2004) 0.96
Side effects of transcranial magnetic stimulation biased task performance in a cognitive neuroscience study. Brain Topogr (2005) 0.95
The influence of gender on phenotype and disease progression in patients with Huntington's disease. Parkinsonism Relat Disord (2012) 0.94
Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum Brain Mapp (2009) 0.94
Volumetric abnormalities associated with cognitive deficits in patients with schizophrenia. Eur Psychiatry (2008) 0.94
Delusional infestation: neural correlates and antipsychotic therapy investigated by multimodal neuroimaging. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.93
Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum. Neurosci Lett (2003) 0.92
Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington's disease. PLoS Curr (2011) 0.92
Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease. J Cereb Blood Flow Metab (2011) 0.92
Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball task. Neuroimage (2011) 0.92
Primary delusional parasitosis treated with olanzapine. Int Psychogeriatr (2007) 0.90
Differential activation of ventrolateral prefrontal cortex during working memory retrieval. Neuropsychologia (2006) 0.89
Valvular strands and ischemic stroke. Eur Neurol (2007) 0.88
Cerebral Amyloidal Angiopathy--a disease with implications for neurology and psychiatry. Brain Res (2013) 0.88
Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness. Hum Brain Mapp (2011) 0.88
Delusional parasitosis and the matchbox sign revisited: the international perspective. Acta Derm Venereol (2010) 0.88
A Europe-wide assessment of current medication choices in Huntington's disease. Mov Disord (2008) 0.88
Default-mode network changes in preclinical Huntington's disease. Exp Neurol (2012) 0.88
NMDA receptor gene variations as modifiers in Huntington disease: a replication study. PLoS Curr (2011) 0.87
Sensorimotor memory for fingertip forces during object lifting: the role of the primary motor cortex. Neuropsychologia (2007) 0.86
Spatial congruence of neuronavigated transcranial magnetic stimulation and functional neuroimaging. Clin Neurophysiol (2002) 0.86
Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacology (Berl) (2002) 0.86
Cortical activation during a pitch discrimination task in tinnitus patients and controls--an fMRI study. Audiol Neurootol (2009) 0.85
Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's disease. Exp Neurol (2011) 0.84
Paliperidone extended-release: does it have a place in antipsychotic therapy? Drug Des Devel Ther (2011) 0.84
Orbitofrontal cortex and impulsivity in borderline personality disorder: an MRI study of baseline brain perfusion. Eur Arch Psychiatry Clin Neurosci (2012) 0.84
Sham or real--post hoc estimation of stimulation condition in a randomized transcranial magnetic stimulation trial. Neurosci Lett (2010) 0.83
Longitudinal task-negative network analyses in preclinical Huntington's disease. Eur Arch Psychiatry Clin Neurosci (2013) 0.83
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease. Br J Clin Pharmacol (2015) 0.83
Current Pharmacological Management in Juvenile Huntington's Disease. PLoS Curr (2012) 0.82
Assessment of motor symptoms and functional impact in prodromal and early huntington disease. PLoS Curr (2011) 0.82
Self-mutilation induced by psychotropic substances: a systematic review. Psychiatry Res (2012) 0.82
Continuous theta-burst stimulation over the dorsal premotor cortex interferes with associative learning during object lifting. Cortex (2008) 0.82
Ziprasidone in Parkinson's disease psychosis. Can J Psychiatry (2004) 0.82
Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration. Mov Disord (2004) 0.81
Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach. Neuroimage Clin (2013) 0.81
Magnetic resonance perfusion imaging of auditory verbal hallucinations in patients with schizophrenia. Schizophr Res (2011) 0.81
A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort. BMC Neurol (2014) 0.81
Functional brain network abnormalities during verbal working memory performance in adolescents and young adults with dyslexia. Neuropsychologia (2010) 0.81
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochem Biophys Res Commun (2012) 0.81
Changes over time in frontotemporal activation during a working memory task in patients with schizophrenia. Schizophr Res (2007) 0.80
Visual system integrity and cognition in early Huntington's disease. Eur J Neurosci (2014) 0.80
Brain structure in preclinical Huntington's disease: a multi-method approach. Neurodegener Dis (2012) 0.80
Aripiprazole and Parkinson's disease psychosis. Am J Psychiatry (2004) 0.79
Exploring the affective component of pain perception during aversive stimulation in borderline personality disorder. Psychiatry Res (2010) 0.79
Cocaine- and amphetamine-regulated transcript is increased in Huntington disease. Mov Disord (2007) 0.79
Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease. J Neurol (2015) 0.78
Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease. Biomed Eng Online (2014) 0.78
Dependence on flupirtine. J Clin Pharmacol (2013) 0.78
Increasing contextual demand modulates anterior and lateral prefrontal brain regions associated with proactive interference. Int J Neurosci (2010) 0.77
Discrepancies in reporting the CAG repeat lengths for Huntington's disease. Eur J Hum Genet (2011) 0.77
The modulating effect of personality traits on neural error monitoring: evidence from event-related FMRI. PLoS One (2012) 0.77
Safety of electroconvulsive therapy in the presence of cranial metallic objects. J ECT (2014) 0.77
"Krokodil":revival of an old drug with new problems. Subst Use Misuse (2012) 0.77
Relationship between transitional objects and personality disorders in female psychiatric inpatients: a prospective study. J Pers Disord (2014) 0.76
Linking Annual Prescription Volume of Antidepressants to Corresponding Web Search Query Data: A Possible Proxy for Medical Prescription Behavior? J Clin Psychopharmacol (2015) 0.76
Somatization disorder treated with electroconvulsive therapy. J ECT (2011) 0.76